FDAnews
www.fdanews.com/articles/171735-alcon-secures-eu-approval-for-new-lens

Alcon Secures EU Approval for New Lens

June 17, 2015

Alcon, a Novartis subsidiary, has gained CE Mark certification for its AcrySof IQ PanOptix trifocal intraocular lens for patients undergoing cataract surgery.

The lens is meant to reduce dependence on glasses as many older patients require additional vision correction following surgery. The product is indicated for adult patients, with or without presbyopia, for near, intermediate and distance vision needs.

The company warns that some patients may experience visual disturbances or have difficulty seeing with the product because of its multifocal lens design, especially under dim lighting.

In Europe, more than 3 million cataract surgeries are performed annually. — Jason Scott